$231 Million is the total value of Endurant Capital Management LP's 65 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 52.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGN | Buy | ALLERGAN PLC | $19,185,000 | +11.3% | 115,072 | +12.4% | 8.32% | +29.2% |
| MRK | Buy | MERCK & CO INC | $15,665,000 | +66.5% | 258,073 | +49.4% | 6.79% | +93.3% |
| ABT | Sell | ABBOTT LABS | $15,602,000 | -5.9% | 255,807 | -7.6% | 6.76% | +9.2% |
| SHPG | Buy | SHIRE PLCsponsored adr | $11,460,000 | +42.1% | 67,893 | +25.7% | 4.97% | +64.9% |
| CI | Buy | CIGNA CORPORATION | $10,955,000 | +217.1% | 64,461 | +212.9% | 4.75% | +267.9% |
| MDT | Sell | MEDTRONIC PLC | $10,678,000 | -1.5% | 124,724 | -7.7% | 4.63% | +14.3% |
| DVA | Sell | DAVITA INC | $9,630,000 | +3.3% | 138,676 | -1.9% | 4.18% | +19.9% |
| ANTM | Sell | ANTHEM INC | $8,792,000 | -9.3% | 36,936 | -16.3% | 3.81% | +5.3% |
| UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $7,159,000 | -27.5% | 64,241 | -23.0% | 3.10% | -15.9% |
| JNJ | Sell | JOHNSON & JOHNSON | $7,114,000 | -51.4% | 58,627 | -48.6% | 3.08% | -43.5% |
| CVS | Buy | CVS HEALTH CORP | $6,890,000 | +6.4% | 107,073 | +2.8% | 2.99% | +23.5% |
| MYL | Buy | MYLAN N V | $6,479,000 | +0.6% | 179,275 | +14.6% | 2.81% | +16.7% |
| BAX | Buy | BAXTER INTL INC | $5,924,000 | +173.1% | 80,229 | +140.6% | 2.57% | +217.2% |
| GILD | Buy | GILEAD SCIENCES INC | $5,870,000 | +65.0% | 82,863 | +75.6% | 2.54% | +91.5% |
| CELG | Buy | CELGENE CORP | $5,655,000 | +98.1% | 71,205 | +122.5% | 2.45% | +130.0% |
| TVTY | Buy | TIVITY HEALTH INC | $5,621,000 | +133.1% | 159,692 | +162.6% | 2.44% | +170.5% |
| AET | Buy | AETNA INC NEW | $5,358,000 | +30.4% | 29,197 | +20.1% | 2.32% | +51.3% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $4,138,000 | -57.4% | 16,867 | -62.9% | 1.79% | -50.6% |
| BDX | Sell | BECTON DICKINSON & CO | $4,040,000 | -62.0% | 16,866 | -65.6% | 1.75% | -55.9% |
| HRC | Buy | HILL ROM HLDGS INC | $3,745,000 | +76.4% | 42,877 | +75.7% | 1.62% | +104.8% |
| HOLX | Sell | HOLOGIC INC | $3,325,000 | -47.9% | 83,656 | -51.1% | 1.44% | -39.6% |
| IQV | New | IQVIA HLDGS INC | $3,289,000 | – | 32,945 | +100.0% | 1.43% | – |
| HCA | Sell | HCA HEALTHCARE INC | $3,155,000 | -27.4% | 30,755 | -31.4% | 1.37% | -15.7% |
| WMGI | Sell | WRIGHT MED GROUP N V | $2,810,000 | +25.3% | 108,258 | -4.3% | 1.22% | +45.3% |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $2,503,000 | – | 22,457 | +100.0% | 1.08% | – |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $2,413,000 | +43.5% | 40,788 | +65.1% | 1.05% | +66.6% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $2,382,000 | -77.5% | 72,841 | -81.2% | 1.03% | -73.9% |
| COO | New | COOPER COS INC | $2,223,000 | – | 9,442 | +100.0% | 0.96% | – |
| CNC | New | CENTENE CORP DEL | $2,170,000 | – | 17,611 | +100.0% | 0.94% | – |
| OXFD | Sell | OXFORD IMMUNOTEC GLOBAL PLC | $2,022,000 | -1.7% | 156,869 | -5.0% | 0.88% | +14.2% |
| SBRA | Sell | SABRA HEALTH CARE REIT INC | $1,976,000 | -60.7% | 90,922 | -68.1% | 0.86% | -54.4% |
| SYNH | Sell | SYNEOS HEALTH INCcl a | $1,838,000 | -73.1% | 39,198 | -79.6% | 0.80% | -68.8% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $1,828,000 | +141.2% | 5,300 | +140.9% | 0.79% | +180.2% |
| A | Buy | AGILENT TECHNOLOGIES INC | $1,819,000 | +35.9% | 29,411 | +47.1% | 0.79% | +57.8% |
| ESRX | Sell | EXPRESS SCRIPTS HLDG CO | $1,798,000 | -52.5% | 23,290 | -57.5% | 0.78% | -44.8% |
| WBA | Sell | WALGREENS BOOTS ALLIANCE INC | $1,749,000 | -77.8% | 29,148 | -75.8% | 0.76% | -74.2% |
| MCK | Buy | MCKESSON CORP | $1,705,000 | +5.1% | 12,779 | +10.9% | 0.74% | +21.9% |
| SYK | New | STRYKER CORP | $1,581,000 | – | 9,360 | +100.0% | 0.69% | – |
| ENDOLOGIX INCnote 2.250%12/1 | $1,518,000 | +1.3% | 1,541,000 | 0.0% | 0.66% | +17.5% | ||
| PRAH | New | PRA HEALTH SCIENCES INC | $1,407,000 | – | 15,068 | +100.0% | 0.61% | – |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $1,387,000 | -20.7% | 30,500 | -7.9% | 0.60% | -8.0% |
| ARRY | Buy | ARRAY BIOPHARMA INC | $1,366,000 | +17.3% | 81,416 | +14.0% | 0.59% | +36.1% |
| PFE | New | PFIZER INC | $1,239,000 | – | 34,152 | +100.0% | 0.54% | – |
| VRX | Sell | VALEANT PHARMACEUTICALS INTL | $1,091,000 | -19.5% | 46,929 | -44.9% | 0.47% | -6.7% |
| OCUL | Sell | OCULAR THERAPEUTIX INC | $964,000 | -17.0% | 142,775 | -20.0% | 0.42% | -3.7% |
| FATE | Sell | FATE THERAPEUTICS INC | $936,000 | -38.3% | 82,572 | -46.8% | 0.41% | -28.3% |
| MNKKQ | New | MALLINCKRODT PUB LTD CO | $909,000 | – | 48,725 | +100.0% | 0.39% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $887,000 | – | 6,714 | +100.0% | 0.38% | – |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $851,000 | -55.4% | 54,504 | -57.1% | 0.37% | -48.2% |
| NVRO | Sell | NEVRO CORP | $806,000 | -13.1% | 10,096 | -5.7% | 0.35% | +0.9% |
| PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $786,000 | -66.3% | 20,803 | -70.9% | 0.34% | -60.9% |
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $706,000 | -85.6% | 3,407 | -85.7% | 0.31% | -83.3% |
| FLDM | New | FLUIDIGM CORP DEL | $680,000 | – | 114,110 | +100.0% | 0.30% | – |
| IMGN | New | IMMUNOGEN INC | $664,000 | – | 68,265 | +100.0% | 0.29% | – |
| VKTX | Sell | VIKING THERAPEUTICS INC | $574,000 | +10.4% | 60,499 | -49.2% | 0.25% | +28.4% |
| BLCM | Sell | BELLICUM PHARMACEUTICALS INC | $530,000 | -44.0% | 71,801 | -50.2% | 0.23% | -35.0% |
| MD | Sell | MEDNAX INC | $409,000 | -90.1% | 9,442 | -87.3% | 0.18% | -88.5% |
| NKTR | New | NEKTAR THERAPEUTICS | $386,000 | – | 7,900 | +100.0% | 0.17% | – |
| AKTX | Sell | AKARI THERAPEUTICS PLCsponsored adr | $352,000 | -1.9% | 180,297 | -8.7% | 0.15% | +14.2% |
| HRTX | New | HERON THERAPEUTICS INC | $343,000 | – | 8,824 | +100.0% | 0.15% | – |
| ABC | New | AMERISOURCEBERGEN CORP | $315,000 | – | 3,692 | +100.0% | 0.14% | – |
| CLSD | New | CLEARSIDE BIOMEDICAL INC | $314,000 | – | 29,400 | +100.0% | 0.14% | – |
| ZGNX | Sell | ZOGENIX INC | $286,000 | -56.2% | 6,473 | -60.3% | 0.12% | -49.2% |
| LH | Sell | LABORATORY CORP AMER HLDGS | $224,000 | -95.3% | 1,249 | -95.8% | 0.10% | -94.6% |
| HSGX | New | HISTOGENICS CORP | $140,000 | – | 56,177 | +100.0% | 0.06% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -3,130 | -100.0% | -0.12% | – |
| AVDL | Exit | AVADEL PHARMACEUTICALS PLCsponsored adr | $0 | – | -55,700 | -100.0% | -0.15% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -25,000 | -100.0% | -0.19% | – |
| MDCO | Exit | MEDICINES CO | $0 | – | -17,000 | -100.0% | -0.21% | – |
| ALRN | Exit | AILERON THERAPEUTICS INC | $0 | – | -75,697 | -100.0% | -0.23% | – |
| QGEN | Exit | QIAGEN NV | $0 | – | -20,500 | -100.0% | -0.25% | – |
| XRAY | Exit | DENTSPLY SIRONA INC | $0 | – | -13,200 | -100.0% | -0.25% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -19,100 | -100.0% | -0.26% | – |
| JAZZ | Exit | JAZZ PHARMACEUTICALS PLC | $0 | – | -5,100 | -100.0% | -0.29% | – |
| TFX | Exit | TELEFLEX INC | $0 | – | -3,600 | -100.0% | -0.34% | – |
| ICLR | Exit | ICON PLC | $0 | – | -8,400 | -100.0% | -0.37% | – |
| DGX | Exit | QUEST DIAGNOSTICS INC | $0 | – | -13,000 | -100.0% | -0.49% | – |
| CAH | Exit | CARDINAL HEALTH INC | $0 | – | -22,542 | -100.0% | -0.53% | – |
| PKI | Exit | PERKINELMER INC | $0 | – | -19,041 | -100.0% | -0.54% | – |
| PPH | Exit | VANECK VECTORS ETF TRpharmaceutical | $0 | – | -25,500 | -100.0% | -0.54% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -19,420 | -100.0% | -0.60% | – |
| MASI | Exit | MASIMO CORP | $0 | – | -20,900 | -100.0% | -0.69% | – |
| DHR | Exit | DANAHER CORP DEL | $0 | – | -21,265 | -100.0% | -0.78% | – |
| PTI | Exit | PROTEOSTASIS THERAPEUTICS IN | $0 | – | -472,012 | -100.0% | -0.84% | – |
| EVHC | Exit | ENVISION HEALTHCARE CORP | $0 | – | -82,174 | -100.0% | -1.18% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
| SC 13G/A | 2023-03-21 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.